CVRX INC

CVRX INC specializes in the design and manufacturing of implantable surgical appliances and medical devices, with a focus on advanced biomedical engineering solutions tailored for clinical deployment. Their technical expertise lies in developing minimally invasive, implantable systems that integrate precision engineering, biocompatible materials, and long-term physiological compatibility. The company demonstrates a strong command of regulatory-compliant manufacturing processes for Class II medical devices, with an emphasis on reliability, sterility, and patient-specific adaptation. Their specialization in implantable technology suggests deep competency in materials science, microfabrication, and post-market surveillance systems aligned with FDA and ISO 13485 standards. CVRX INC has delivered critical medical hardware to the Department of Veterans Affairs, indicating a focused relationship with federal healthcare providers serving veteran populations. The nature of the awarded implant suggests the company supports veteran-specific rehabilitation, neurological, or cardiovascular care pathways, likely contributing to long-term therapeutic outcomes through durable, implantable medical devices. This engagement reflects a trusted supplier relationship within VA’s specialized prosthetics and surgical supply channels. The contractor’s primary industry focus is surgical appliance and supplies manufacturing under NAICS 339113, positioning them as a niche player in the implantable medical device market. They operate at the intersection of biomedical innovation and clinical necessity, serving high-acuity care environments requiring engineered solutions that meet stringent safety and performance benchmarks. CVRX INC is a small business structured as a 2L entity, headquartered in Minneapolis, Minnesota. While no federal certifications are listed, their manufacturing activities imply adherence to FDA Quality System Regulation and ISO standards for medical device production. Their geographic presence supports regional access to academic medical centers and federal healthcare infrastructure, reinforcing their role as a specialized supplier within the U.S. government’s medical technology ecosystem.